Similarly, CDC23 is a cell cycle regulator that contributes to breakdown of mitotic proteins, and in glioblastoma models, CDC23 knockdown is associated with increased mitotic activity.33 Higher CDC23 expression was observed in the LTS cohort, consistent with existing literature characterizing the role of its protein product. The gene discussed is RGCC; the disease is glioblastoma.